Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neucardin in Chronic Systolic Heart Failure
NCT05949801Phase 3Completed
- Sponsor
- Zensun
- Start
- Apr 2023
- Primary completion
- Aug 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of neucardin in chronic systolic heart failure (HFrEF), sponsored by Zensun. Started Apr 2023; status: completed.
02
Drugs
neucardin
03
Conditions
chronic systolic heart failure (HFrEF)
Beyond the preview
Go deeper on NCT05949801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05949801.